Tag Archives: Basaglar

US FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

Washington: The US Food and Drug Administration on Wednesday approved Basaglar (insulin glargine injection), a long-acting human insulin analogue to improve glycaemic control in adult and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Posted in NEWS, Pharmaceuticals | Tagged , , , , | Leave a comment